Synapse Medicine
Synapse Medicine provides the most advanced AI solutions for #Healthcare and drugs prescriptions.
Total raised
€35M
€34,571,800
Funding rounds
3
Investors
5
distinct backers
Active since
2018-12
latest 2022-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood39
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 9y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-01 | Series B | €25M | BNP Paribas Development,Fleur Pellerin investment fund,Korelya Capital,MACSF,XAnge | View deal → |
| 2020-07-06 | Other | €7.1M | MACSF | View deal → |
| 2019-01-01 | Seed | €2.5M | XAnge | View deal → |
Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software